What is the primary purpose of Risk Evaluation and Mitigation Strategies (REMS) according to FDA regulations?

• A. To enhance the marketing of prescription drugs
• B. To ensure benefits of certain prescription drugs outweigh their risks
• C. To simplify the approval process for new medications
• D. To regulate over-the-counter medications

Answer: (B)

The primary purpose of Risk Evaluation and Mitigation Strategies (REMS) is to ensure that the benefits of certain prescription drugs outweigh their risks. REMS are designed by the FDA for medications that have serious safety concerns. By implementing these strategies, the FDA aims to manage and mitigate the risks associated with these medications while still allowing patients access to potentially life-saving treatments.

REMS may include requirements for healthcare providers, such as training or certification, as well as patient education, monitoring, and reporting responsibilities. This careful balancing act helps to promote patient safety while acknowledging that some medications are essential despite their risks. By focusing specifically on the benefits versus risks of the drugs in question, REMS plays a crucial role in the overall drug approval and post-marketing processes.

Other options, while related to drug regulation, do not capture the central intent of REMS. For instance, enhancing marketing or simplifying approval processes are not within the scope of REMS objectives, and regulating over-the-counter medications falls outside the framework specifically designed for prescription drugs that necessitate risk mitigation.